Louise Goksøyr

6PUBLICATIONS
38CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)AllergyCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 16, 2026
Preimmunization of SPF Mice With Capsid Virus-like Particle Has no Effect on CD8+ Immune Memory and Skin Inflammation in an Ovalbumin-Induced Dermatitis Model.

|May 14, 2025
A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25.

Cyrielle Fougeroux, Sven Hendrik Hagen, Louise Goksøyr

|Jan 21, 2023
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines.

Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson

|May 28, 2022
Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis.

Louise Goksøyr, Anders B Funch, Anna K Okholm

|Feb 11, 2022
The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization.

Azad Farzadfard, Jannik Nedergaard Pedersen, Georg Meisl

|Jan 13, 2021
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.

Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn

Pageof 1

Frequent Collaborators

6 joint publications

Adam Frederik Sander Bertelsen

3 joint publications

Morten Agertoug Nielsen

2 joint publications

Elena Ethel Vidal-Calvo

1 joint publications

Cyrielle Fougeroux